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PAMP-Polymer Conjugate Synthetic Procedures.
Lipoteichoic Acid-Polymer Conjugate Synthesis (2a). Lipoteichoic acid (LTA) was fluorescently labeled by reacting amine containing backbone of LTA (2 mg, 0.2 mol) with rhodamine B isothiocyanate (RITC) (10.7 L of 10 mg/mL solution in DMF, 0.2 mol) in phosphate buffered saline (PBS) buffer (pH 7.4 with 1 mM EDTA) for 15 min at RT. Subsequently, the remaining amines were thiolated by incubating the RITC-LTA solution with N-succinimidyl-S-acetylthiopropionate (SATP) 1 (0.16 mg per 1 mg LTA) in DMF for 1 h at RT. The LTA solution was filtered using a Centriprep Centrifugal Filter Device (3K device). The thiol was deprotected by incubating the filtered LTA solution with hydroxylamine in PBS buffer (100 L, pH 7.4 with 25 mM EDTA and 0.5 M hydroxylamine) at 4 °C overnight (~16 h). The thiolated LTA was filtered using a Centriprep Centrifugal Filter Device (3K device). The extent of RITC conjugation was quantified via UV-Vis to provide one RITC molecule for every five LTA molecules (1:5, RITC : LTA). Thiolation of LTA was confirmed via Ellman's Assay. Thiols per LTA molecule were determined relative to a cysteine standard curve, which resulted in a mixture where 60% of the LTA contained a thiol. (This indicated that one LTA potentially contained more than one thiol.) The thiolated LTA (150 L) was then reacted with the SM(PEG) 6 linker (60 L of 20 mg/mL solution in DMSO) for 30 min at RT. The resulting conjugate was passed through a NAP-5 Column pre-equilibrated with PBS buffer (pH 7.4). The conjugate was quantified via UV-Vis and confirmed using proton nuclear magnetic resonance ( 1 H NMR) and thin-layer chromatography (TLC). 1 H NMR spectra were taken in D 2 O. The TLC was run in 65:25:4 CHCl 3 : MeOH : H 2 O.
CpG-ODN-Polymer Conjugate Synthesis (2b).
Single stranded CpG-ODN1826 (5'-TCCATGACGTTCCTGACGTT-3') was obtained with a 3'-disulfide modification. The 3'-disulfide modification was reduced to the free thiol using 3% tris(2-carboxyethyl)phosphine hydrochloride (TCEP) in water (400 L). The reduced CpG-ODN1826 was precipitated in EtOH (1.5 mL) and 3M NaOAc (50 L) and placed in a -80 °C freezer for 30 min. The precipitated CpG-ODN1826 was centrifuged at 13,000 RPM and 4 °C for 20 min. The supernatant was removed and the precipitated CpG-ODN1826 was rinsed with EtOH (200 L). The CpG-ODN1826 was placed in a speed-vacuum to remove excess solvent and dry the reduced CpG-ODN1826. The reduced CpG-ODN1826 (2.0 mM) was resuspended in Tris-EDTA (TE) buffer (1x) and passed through a NAP-5 Column, which was pre-equilibrated with TE buffer (1x). Subsequently, the SM(PEG) 6 linker (120 L of 20 mg/mL solution in DMSO) was added over 2 h to the eluted DNA (0.40 mM, 100 L). The reaction mixture was incubated at RT. The pH of the reaction was monitored to ensure a constant pH ~8. If slightly acidic, PBS buffer (40 L) was added to the reaction mixture. Maintaining a slightly basic pH facilitated deprotonation of the thiol to increase the rate of conjugate addition. The reaction mixture was passed through a NAP-5 Column pre-equilibrated with PBS buffer (pH 7.4). The conjugate was quantified via UV-Vis and confirmed using MALDI-MS.
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PAMP Cell Surface Modification of LLCs with LTA-Polymer (2a) and/or CpG-ODNPolymer (2b) to Provide PAMP_LLC Constructs (3a, 3b, or 3c). A solution of conjugate 2a or 2b or 2a and 2b (36 M, 100 L) in PBS buffer was incubated with Lewis Lung Carcinoma (LLC) cells (2x10 6 cells) for 30 min at RT. The solution was mixed thoroughly using a vortexer. The cell solution was centrifuged at 2500 RPM and RT for 10 min, and the supernatant removed. The modified cells were rinsed in PBS buffer (1 x 200 L), then cell media (2 x 200 L) and finally incubated with dendritic cells. The cell surface modification was quantified using flow cytometry and fluorescent microscopy. To confirm the modification of CpG_LLCs, the 6-FAM-labeled CpG-ODN1826 anti-sense strand (10 L, 100 M) was incubated with the modified CpG_LLCs. The solution was incubated for 30 min at 0 °C removed from light. The cells were rinsed using PBS buffer (2 x 200 L) and resuspended in PBS buffer (100 L) to be analyzed. To confirm the LTA_LLC modification, the LTA was labeled with rhodamine B as mentioned in the synthesis of 2a.
Cell Culture and Flow Cytometry Procedures.
Bone Marrow-Derived Dendritic Cell Harvest and Culture. Femur bones were removed from 6-week-old C57Bl/6 mice according to Matheu, et al., 2 and the bone marrow was extracted into PBS buffer. The cell suspension was made into a homogeneous solution using a pipette and subsequently filtered through a 70 m cell strainer (Fisher Scientific). The cell solution was centrifuged at 300 RCF for 10 min at RT. The supernatant was removed, and ACK Lysing Buffer (Lonza) (3 mL) was added to the cell pellet and incubated for 2 min at RT. PBS buffer (13 mL) was then added to the cell suspension, and the cell solution was centrifuged at 300 RCF for 10 min at RT. The cell pellet was resuspended in RPMI 1640 (Fisher Scientific Hyclone), and centrifuged at 300 RCF for 10 min at RT. The cell pellet was resuspended in BMDC primary media. Harvested cells were then counted and plated at 1 million cells/mL density in 100 mm petri dishes (10 mL total media) and incubated at 37 °C in a CO 2 incubator (day 0 of cell culture). On day 3, 10 mL of BMDC primary media was added to each petri dish. Day 5 BMDCs were released using a pipette, centrifuged at 300 RCF for 10 min at RT, and replated in 24-well plates at 1.2 x 10 6 cells/mL density for cell surface marker activation and cytokine profile flow cytometry experiments.
General Procedure for Flow Cytometry for Cell Surface Marker Upregulation.
BMDCs were incubated individually with each PAMP_LLC (3a, 3b, or 3c) (9:1 BMDCs : PAMP_LLCs in 0.5 mL culture media) for 18 h at 37 °C in a CO 2 incubator. Stimulated BMDCs were released from the plate and transferred to 1 mL eppendorf tubes. The cells were centrifuged at 2500 RPM and 4 °C for 10 min and the supernatant was removed. The cell pellet was resuspended in cold FACS buffer (100 L) and incubated with CD16/32 FcR blocking antibodies g/1*10 6 cells) (BioLegend) on ice for 10 min. The cell suspension was centrifuged at 2500 RPM for 10 min at 4 °C and the supernatant removed. The cell pellet was resuspended in cold FACS buffer (100 L) and incubated with FITC-CD11c g/1*10 6 cells) and PE-CD86g/1*10 6 cells), -CD40g/1*10 6 cells), -MHCIIg/1*10 6 cells), or -CD80g/1*10 6 cells)) on ice and removed from light for 30 min. Cold FACS buffer (300 L) was added to each sample. The cell suspension was centrifuged at 2500 RPM and 4 °C for 10 min and the supernatant was removed. The cells were then rinsed with cold FACS buffer (300 L) one final time and the supernatant removed. The dendritic cells were resuspended in cold FACS buffer (200 L) and kept on ice until being loaded onto the flow cytometer.
General Procedure for Intracellular Cytokine Flow Cytometry Staining.
BMDCs were incubated individually with a solution of PAMP_LLC (3a, 3b, or 3c) (9:1 BMDCs : PAMP_LLCs in 0.5 mL culture media) for 8 h at 37 °C in a CO 2 incubator. GolgiPlug (BD Biosciences), containing Brefeldin A, was added to cell culture (according to BD Biosciences Protocol) for the final 4 h of culture. After 8 h, stimulated BMDCs were released from the plate and transferred to 1 mL eppendorf tubes. The cells were centrifuged at 2500 RPM and 4 °C for 10 min and the supernatant removed. The cell pellet was resuspended in cold FACS buffer (100 L) and incubated with CD16/32 FcR blocking antibodies g/1*10 6 cells) on ice for 10 min. The cell suspension was centrifuged at 2500 RPM and 4 °C for 10 min and the supernatant removed. The cell pellet was resuspended in cold FACS buffer (100 L) and incubated with FITC-CD11cg/1*10 6 cells) on ice and removed from light for 30 min. Cold FACS buffer (300 L) was added to each sample. The cell suspension was centrifuged at S6 2500 RPM for 10 min at 4 °C and the supernatant removed. The cells were rinsed with cold FACS buffer (300 L) one more time and the supernatant removed. The cell pellet was resuspended in 100 L BD Cytofix/Cytoperm solution and incubated on ice and removed from light for 20 min. The cell suspension was centrifuged at 2500 RPM and 4 °C for 10 min and the supernatant removed. BMDCs were washed in BD Perm/Wash solution (2 x 300 L) and the supernatant removed. The cell pellet was resuspended in cold FACS buffer (100 L) and incubated with APC-IFN-g/1*10 6 cells) -TNF-g/1*10 6 cells) -IL-6 g/1*10 6 cells), -IL-10g/1*10 6 cells), or -IL-12 g/1*10 6 cells)) on ice and removed from light for 30 min. Cold FACS buffer (300 L) was added to each sample. The cell suspension was centrifuged at 2500 RPM and 4 °C for 10 min and the supernatant removed. The cells were rinsed with cold FACS buffer (300 L) one more time. BMDCs were resuspended in cold FACS buffer (200 L) and kept on ice until analysis via flow cytometer.
General Procedure for RAW264.7 Macrophage (RAW-Blue) NF-B assay.
3 RAW-Blue cells were plated at 10*10 4 cells/mL density (180 L) in 96-well plates using testing media as described in Methods and Materials. RAW-Blue cells were incubated individually with 20 L of each PAMP_LLC (3a, 3b, or 3c) (9:1 RAW-Blue : PAMP_LLCs in 200 L total cell media volume) for 18 h at 37 °C in a CO 2 incubator. Cell media (50 L) from the stimulated RAW-Blue cells was removed, placed into a 96-well plate, and incubated with QUANTI-Blue solution (Invivogen) (150 L) for 1 h at 37 °C in a CO 2 incubator. The absorbance (620 nm) was measured using a Bio-Tek Quant microplate spectrophotometer.
MALDI-MS.
CpG-ODN-Polymer Conjugate. The reaction mixture was passed through ZipTip C18 (Millipore) according to Millipore protocol: A ZipTip C18 was equilibrated with 50% acetonitrile/water (2 x 10 L) and subsequently 0.1 M triethylammonium acetate (TEAA) (3 x 10 L). The reaction mixture was passed through the ZipTip C18 (10 x 10 L). The ZipTip C18 was washed with 0.1 M TEAA buffer (3 x 10 L) followed by nanopure water (3 x 10 L). Conjugate 2b was eluted using 50% acetonitrile/water (3 x 10 L). Purified conjugate 2b was dried using a speed-vacuum and resuspended in 0.36 M 3-hydroxypicolinic acid matrix (1:1 acetonitrile : 300 mM ammonium citrate solution in 50% acetonitrile/water) (2.0 L). The sample was spotted on a MALDI plate and analyzed in negative ion mode.
Confocal Microscopy.
Fluorescent Cell Labeling with DiO and DiI and Confocal Microscopy Colocalization Experiments.
Stock solutions of DiI and DiO dye (1 mg/mL) were prepared in DMSO. Working solutions of DiI and DiO (100 g/mL) were prepared by diluting the stock solutions with glucose labeling buffer (300 mM glucose and 10 mM HEPES in nanopure water). 4 The cells were plated one day prior in 6-well plates at 2*10 5 cells/mL. Before labeling the cells, the media was removed. JAWS II and LLC cell lines were suspended in DiO or DiI solutions (0.5 mL of 100 g/mL), respectively, and incubated at 37 °C in a CO 2 incubator for 2 h. The DiI or DiO solution was then removed. The cells were washed with glucose buffer (2 x 1 mL) and resuspended in cell media. The LLCs were labeled with 2a, 2b, or 2a and 2b as described in the synthetic procedures. The PAMP_LLCs were incubated with the dendritic cell line overnight (~ 14-18 h) at 37 °C. The cell media was removed. The cells were then resuspended in PBS buffer, and analyzed via confocal microscopy. 1 H NMR spectra of SATP reagent (blue-top), 1 LTA (green-middle), and acetyl protected sulfhydryl LTA (black-bottom). All samples were taken in D 2 O. D-Ala-H was observed at 4.16 ppm. SATP methylene protons were observed at 3.59 and 3.68 ppm.
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Figure S8.
1 H NMR spectra of SATP reagent (blue-top), 1 LTA (green-middle), and acetyl protected sulfhydryl LTA (black-bottom). All samples were taken in D 2 O. D-Ala-H was observed at 1.50 (protected sulfhydryl LTA) and 1.66 ppm (starting material LTA). SATP methyl protons were observed at 2.42 ppm. Figure S9 . FPLC trace of LTA (red), SM(PEG) 6 linker (blue), and 2a (green) (samples run in DPBS). LTA conjugation to SM(PEG) 6 linker does not result in a significant shift in the FPLC trace, so 2a cannot be definitively confirmed using FPLC. 
Extent of RITC-LTA_LLC Labeling
Figure S14. RAW264.7 macrophage NF-B stimulation via alkaline phosphatase secretion. Data displays absorbance (620 nm) caused by macrophage cell incubation with PAMP_LLC constructs for 19 h at 37 °C, which correlates to NF-B stimulation. LLCs were modified with half of the concentration of PAMP-polymer conjugate (14 M) compared to the full concentration (28 M) to determine that the activation from CpG_LTA_LLCs is more than the additive stimulation from just CpG_LLCs and LTA_LLCs. More important, the CpG_LTA_LLCs displayed the greatest stimulation over using a single PAMP. Data obtained over six independent experiments, where p < 0.025 for CpG_LLCs relative to CpG_LTA_LLCs, p < 0.05 for LTA_LLCs relative to CpG_LTA_LLCs, and p < 0.01 for the unmodified LLCs relative to all PAMP_LLCs and for the CpG_LTA_LLCs relative to all other samples. ‡ ‡ ‡ DiO is a lipophilic, membrane bound green fluorophore. DiI is a lipophilic, membrane bound red fluorophore. These lipophilic dyes are commonly used to track multiple cells. There are hypotheses that these dyes can exchange/diffuse between cells, since they embed into the cell membrane via lipophilic interactions. However, dialkylcarbocyanine dyes have been used for many years in the field of immunology for cell labeling and tracking experiments. 7, 8 Also, no DiI-labeled CpG_LLCs were observed with DiO-labeled cell interiors and no DiI was observed on the outer cell membrane of the DCs. These results strongly suggest that the dendritic cells engulfed the CpG_LLCs and that the images were not a result of the interchange of the lipophilic dyes.
‡ ‡ ‡ ‡ DC stimulation using CpG-ODN recruits TLR9 from the ER through the Golgi to endosomal compartments via membrane fusion. TLR9 is processed and cleaved after passing through the Golgi to provide functional TLR9 in the endosome as opposed to full-length (unprocessed, nonfunctional) TLR9, which does not become activated by ligands. 9, 10 
